The outcomes of the analysis exhibited a significant increase in the density of CD73-positive or CD90-positive MSC cells in the tumor microenvironment following the onset of drug resistance as compared to the corresponding drug-sensitive samples (as demonstrated in Fig. 1B). This evidence concerns the gene NT5E and neoplasm.